Fang Tian, PhD

Director of Biological Content at ATCC

Speaker

Dr. Fang Tian is Director of Biological Content at ATCC, where she leads scientific strategy and product innovation for cell biology products, cell culture technologies, and in vitro model systems. She oversees ATCC's human and animal cell line and hybridoma portfolios and supports initiatives focused on advanced cell models, bioproduction-relevant cell culture systems, and product development for research and biotechnology applications. With extensive experience in cell and molecular biology, Dr. Tian has contributed to scientific thought leadership and product strategy efforts focused on emerging technologies and next-generation cell-based platforms. Prior to joining ATCC, she held research positions at Massachusetts General Hospital, Harvard Medical School, and the Hillman Cancer Institute at UPMC